Try it
OBG · Gynaecological oncology: platinum sensitivity
Sample itemA woman with ovarian cancer completed carboplatin-paclitaxel 10 months ago and now has a rising CA-125 with a pelvic recurrence on imaging. How is her disease classified?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Platinum-sensitive relapse, as recurrence occurred more than 6 months after platinum
Platinum-sensitive disease relapses more than 6 months after completing platinum therapy, platinum-resistant disease within 6 months, and platinum-refractory disease progresses during treatment. Platinum-sensitive relapses are retreated with a platinum-based combination and can respond well, and secondary cytoreduction may be considered in selected cases. Maintenance with PARP inhibitors may be used.
Option by option
A. Platinum-sensitive relapse, as recurrence occurred more than 6 months after platinum (correct)
Correct. A 10-month interval defines platinum-sensitive relapse.
B. Platinum-resistant relapse
Resistance requires relapse within 6 months.
C. Stage IV by definition
Relapse does not by itself change the initial stage.
D. Platinum-refractory disease
Refractory disease progresses while on platinum.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…
- Obstetric immunologyAn Rh-negative mother delivers an Rh-positive baby. When should anti-D immunoglobulin be…